SYNTHESIS AND ANTITUMOR ACTIVITY OF 5-BROMO-1-MESYLURACIL

REFERENCES

• MacCoss , M. and Robins , M. J. 1990 . Chemistry of Antitumor Agents , Edited by: Wilman , D. E.V. UK : Blackie and Son .
   Google Scholar
• Robins , M. J. and Kinin , G. D. 1990 . Chemistry of Antitumor Agents , Edited by: Wilman , D. E.V. UK : Blackie and Son .
   Google Scholar
• Lendnicer , D. and Mitscher , L. D. 1977 . The Organic Chemistry of Drug Synthesis , Vol. 1 , 120 – 132 . New York : John Wiley .
   Google Scholar
• Mohamadi , F. , Spels , M. M. and Grindey , G. B. 1992 . Sulfonylureas: a new class of cancer chemotherapeutic agents . J. Med. Chem. , 35 : 3012 – 3016 .
   PubMed Web of Science ®Google Scholar
• Howbert , J. J. , Grossman , C. S. , Crowell , T. A. , Rieder , B. J. , Harper , R. W. , Kramer , K. E. , Tao , E. V. , Aikins , I. , Poore , G. A. , Rinzel , S. M. , Grindey , G. B. , Shaw , W. N. and Todd , G. C. 1990 . Novel agents effective against solid tumor. The Diarylsulfonylureas. Synthesis, activities and analysis of quantitative structure-activity relationships . J. Med. Chem. , 3 : 2393 – 2407 .
   Web of Science ®Google Scholar
• Kassnar , B. , Krizmanić , I. and Zinić , M. 1997 . Synthesis of the sulfonylpyrimidine derivatives as a new type of sulfonylcycloureas . Nucleosides Nucleotides , 16 : 1067 – 1071 .
   Google Scholar
• Zinić , B. , Krizmanić , I. , Vikić-Topić , D. and Zinić , M. 1999 . 5-Bromo- and 5-iodo-N-1-sulfonylated cytosine derivatives. Exclusive formation of keto-imino tautomers . Croat. Chem. Acta , 72 : 957 – 966 .
   Web of Science ®Google Scholar
• Zinić , B. , Zinić , M. and Krizmanić , I. 2003 . Sulfonylpyrimidine Derivatives with Anticancer Activity , Ruder Bosković Institute .
   Google Scholar
• Glavas-Obrovac , L. J. , Karner , I. , Zinić , B. and Pavelić , K. 2001 . Antineoplastic activity of novel N-1-sulfonylpyrimidine derivatives . Anticancer Res. , 21 : 1979 – 1986 .
   PubMed Web of Science ®Google Scholar
• Kumar , R. , Wiebe , L. I. and Knaus , E. E. 1994 . A mild and efficient methodology for the synthesis of 5- halogenouracil nucleosides that occurs via a 5-halogeno-6-azido-5,6-dihydro intermediate . Can. J. Chem. , 72 ( 9 ) : 2005 – 2010 .
   Web of Science ®Google Scholar
• Martirosyan , Z. A. , Gunar , V. I. and Zav'yalov , S. S. 1970 . Tosylation of nucleobases . Izv. Akad. Nauk SSSR, Ser. Him. , : 1841 – 1844 .
   Google Scholar
• Kaldrikyn , M. A. , Geboyan , V. A. , Ter-Yakharyn , Yu. Z. , Paronikyan , R. V. , Garibdzhanyan , B. T. , Stepanyan , G. M. and Paronikyan , G. M. 1986 . Synthesis and biological activity of N′-4-alkoxybenzenesulfonyl-5-halouracis . Khim. Farm. Zh. , 20 : 928 – 932 .
   Google Scholar
• Tada , M. 1975 . Antineoplastic agents. Synthesis of some 1-substituted 5-fluorouracil derivatives . Chem. Lett. , 2 : 129 – 130 .
   Web of Science ®Google Scholar
• Houghton , J. A. and Houghton , P. J. 1983 . Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma . Eur. J. Clin. Oncol. , 19 : 807 – 815 .
   PubMedGoogle Scholar
• Tazawa , K. , Sakamoto , T. , Kuroki , Y. , Ysmashita , I. , Okamoto , M. , Katuyama , S. and Fujimaki , M. 1997 . Inhibitory effects of fluorinated pyrimidines, 5′-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma assessment of inhibitory activity and adverse reactions at the maximum tolerated dose . Clin. Exp. Metastasis , 15 : 266 – 271 .
   PubMed Web of Science ®Google Scholar
• Fukushima , M. , Fujioka , A. , Uchida , I. , Nakagawa , F. and Takechi , T. 2001 . Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistence to 5-fluorouracil(5-FU) in human cancer xenografts in vivo . Eur. J. Cancer , 137 : 1681 – 1687 .
   Web of Science ®Google Scholar
• Kolberg , M. , Strand , K. R. , Graff , P. and Anderson , K. K. 2004 . Structure, function, and mechanism of ribonucleotide reductase . Biochem. Biophys. Acta , 1699 : 1 – 34 .
   PubMed Web of Science ®Google Scholar
• Takahaski , T. , Nakashima , A. , Kanazawa , J. , Yamaguchi , K. , Akinaga , S. , Tamaoki , T. and Okabe , M. 1998 . Metabolism and ribonucleotide reductase inhibition of (E)-2′ deoxy-2′-(fluormethylene)cytidine MDL 101.731 in human cervical carcinoma HeLa S3 cells . Commun. Chemother. Pharmacol. , 41 : 268 – 274 .
   PubMed Web of Science ®Google Scholar
• Hurta , R. A. and Wright , J. A. 1992 . Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent . J. Biol. Chem. , 267 : 7066 – 7071 .
   PubMed Web of Science ®Google Scholar
• Smith , B. D. and Karp , J. E. 2003 . Ribonucleotide reductase: an old target with new potential . Leuk. Res. , 27 : 1075 – 1076 .
   PubMed Web of Science ®Google Scholar
• Weber , G. 2004 . Significance of enzyme degradation rate and enzyme inhibition in targeted chemotherapy . Advan. Enzyme Regul. , in press
   PubMedGoogle Scholar
• Lai , M. H.T. and Weber , G. 1983 . Increased concentration of thymidine kinase in rat hepatoma . Biochem. Biophys. Res. Commun. , 111 : 280 – 287 .
   PubMed Web of Science ®Google Scholar
• Niedzwicki , J. G. , Ilzsch , M. H. , ElKouni , M. H. and Cha , S. 1984 . Structure activity relationship of ligands of the pyrimidine nucleoside phosphorylases . Biochem. Pharmacol. , 33 : 2383 – 2395 .
   PubMed Web of Science ®Google Scholar
• Pizzomo , G. , Cao , D. L. , Leffert , J. J. , Russel , R. L. , Zhang , D. K. and Handschumacher , R. E. 2002 . Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update . Biochem. Biophys. Acta , 1587 : 133 – 144 .
   PubMed Web of Science ®Google Scholar
• Liu , M. , Cao , D. , Russell , R. , Handschumacher , R. E. and Pizzomo , G. 1998 . Expression, characterization, and detection of human uridine phosphorylase and identification of variant phosphate activity in selected human tumors . Cancer Res. , 58 : 5418 – 5424 .
   PubMed Web of Science ®Google Scholar
• Matsui , H. , Suzuka , K. , Iitsuka , Y. , Yaazawa , K. , Tanaka , N. , Mitsuhashi , A. , Seki , K. and Sekiya , S. 2002 . Salvage combination chemotherapy with S-fluorouracil and actinomycin D for patients eighth refractory, high-risk gestational trophoblastic tumors . Cancer , 95 : 1051 – 1054 .
   PubMed Web of Science ®Google Scholar
• Ardalan , B. M. , Buscaglia , D. and Schein , P. S. 1978 . Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response . Biochem. Pharmacol. , 27 : 2009 – 2013 .
   PubMed Web of Science ®Google Scholar
• Guo , Y. P. , Kotova , E. , Chen , Z. S. , Lee , K. , Hopper-Borge , E. , Belinsky , M. G. and Kruh , G. D. 2003 . MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide effux pump and a resistance factor for fluoropyrimidine 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine . J. Biol. Chem. , 278 : 29509 – 29514 .
   PubMed Web of Science ®Google Scholar
• Anton , A. , Aranda , E. , Carrato , A. , Marcuello , E. , Massuti , B. , Vervantes , A. , Abad , A. , Sastre , J. , Fenandez-Martos , C. , Gallen , M. , Diaz-Rubio , E. , Huarte , L. and Ba lcel ls , M. 2003 . Irinotecan (CPT-11) in metastatic colorectal cancer patiens resistant to 5-fluorouracil(5-FU): a phase II study . Methods Find. Exp. Clin. Pharmacol. , 25 : 639 – 643 .
   PubMedGoogle Scholar
• Liao , L. , Kupchan , S. M. and Horowitz , S. B. 1976 . Mode of action of the antitumor compound bruceantin an inhibitor of protein synthesis . Mol. Pharmacol. , 12 : 167 – 176 .
   PubMed Web of Science ®Google Scholar
• Christopherson , R. I. , Yu , M. L. and Jones , M. 1981 . An overall radioassay for the first three reactions of de novo pyrimidine synthesis . Anal. Biochem. , 111 : 240 – 249 .
   PubMed Web of Science ®Google Scholar
• Cadman , E. , Heimer , R. and Benz , C. 1981 . The influence of methotrexate pretreatment on S-flaxouracil metabolism in L1210 cells . J. Biol. Chem. , 256 : 1695 – 1704 .
   PubMed Web of Science ®Google Scholar
• Agarwal , R. P. , He , J. , Bansal , M. and Gupta , V. 1995 . Affect of long-term zidovudine exposure on salvage and de novo purine and pyrimidine nucleotide syntheses . Biochim. Biophys. Acta , 1266 : 223 – 228 .
   PubMed Web of Science ®Google Scholar
• Lowry , O. H. , Rosebrough , N. J. , Farr , A. L. and Randal , R. 1951 . Protein measurement with the Folin-phenol reagent . J. Biol. Chem. , 193 : 265 – 275 .
   PubMed Web of Science ®Google Scholar
• Sedwick , W. D. , Wang , T. S. and Kom , D. 1972 . Purificaton and properties of nuclear and cytoplasmic deoxyribonucleic acid polymerases from human Kb cells . J. Biol. Chem. , 247 : 5026 – 5033 .
   PubMed Web of Science ®Google Scholar
• Eichler , D. C. and Fisher , P. A. 1977 . Effect of calcium on the recovery distribution of DNA polymerase α form cultured human cells . J. Biol. Chem. , 252 : 4011 – 4014 .
   PubMed Web of Science ®Google Scholar
• Anderson , K. M. , Mendelson , I. S. and Guizik , G. 1975 . Solubilized DNA-dependent nuclear RNA polymerases from the mammary glands of late-pregnant rats . Biochem. Biophys. Acta , 383 : 56 – 66 .
   PubMedGoogle Scholar
• Moore , E. C. and Hulbert , R. B. 1966 . Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors . J. Biol. Chem. , 24 ( 20 ) : 4802 – 4809 .
   Google Scholar
• Matsmoto , M. , Tihan , T. and Cory , J. G. 1990 . Effects of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture . Cancer Chemother. Pharmacol. , 26 : 323 – 329 .
   PubMed Web of Science ®Google Scholar
• Kalman , S. M. , Duflield , P. H. and Brzozwki , T. J. 1966 . Purification and properties of a bacterial carbamyl phosphate synthetase . J. Biol. Chem. , 241 ( 8 ) : 1871 – 1877 .
   PubMed Web of Science ®Google Scholar
• Koritz , S. B. and Cohen , P. P. 1968 . Calorimetric determination of carbamyl amino acid and related compounds . J. Biol. Chem. , 243 : 3924
   PubMedGoogle Scholar
• Kampf , A. , Bariknecht , R. , Schaffer , P. , Osaki , S. and Mertes , M. P. 1976 . Synthetic inhibitors of E. coli, calf thymus and Ehrlich ascites tumor thymidylate synthetase . J. Med. Chem. , 19 ( 7 ) : 903 – 908 .
   PubMed Web of Science ®Google Scholar
• Peters , G. J. , Van der Wilt , C. L. , Van Groeningen , C. J. , Smid , K. , Meijer , S. and Pinedo , H. M. 1994 . Thymidilate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil . J. Clin. Oncol. , 12 : 2035 – 2042 .
   PubMed Web of Science ®Google Scholar
• Maley , F. and Ochoa , S. 1958 . Enzymatic phosphorylation of deoxycytidylic acid . J. Biol. Chem. , 233 : 1538 – 1543 .
   PubMed Web of Science ®Google Scholar
• Weber , G. , Shiotani , T. , Kizaki , H. , Tzeng , D. , Williams , J. C. and Gladstone , N. 1978 . Biochemical strategy of the genome as expressed in regulation of pyrimidine metabolism . Adv. Enzyme Regul. , 16 : 3 – 19 .
   Google Scholar
• Ho , Y. K. , Hakala , T. and Zakrzewski , S. 1972 . 5-(1-Adamantyl)pyrimidines as inhibitors of folate metabolism . Cancer Res. , 32 : 1023 – 1028 .
   PubMed Web of Science ®Google Scholar
• Martin , D. W. 1972 . Radioassay for enzimatic production of glutamate from glutamine . Anal. Biochem. , 46 : 239 – 242 .
   PubMed Web of Science ®Google Scholar